Shanghai Clinical Cohort - Adrenal Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-25

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As a vital organ responsible for producing life-sustaining hormones, the adrenal gland is associated with a wide range of diseases. These diseases affect multiple systems throughout the body and carry a high rate of mortality and disability. Current diagnosis and treatment face several challenges: significant variability in hormone testing results, inaccurate localization via imaging techniques, unclear molecular characteristics of adrenal tumors, and difficulty in determining prognosis through pathology. Therefore, establishing a clinical research cohort for adrenal diseases is essential. Such a cohort will enable in-depth exploration of disease mechanisms, identification of disease subtypes, optimization of diagnostic criteria, evaluation of treatment efficacy, advancement of personalized medicine, and formulation of prevention and treatment strategies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

China National Study of Adrenal Venous Sampling

NCT06192238

Hyperaldosteronism

NOT_YET_RECRUITING

Effect of Treatment With Stress-Doses Glucocorticoid in Patients With Acute Respiratory Distress Syndrome (ARDS)

NCT00773058

Acute Respiratory Distress Syndrome Adrenal Insufficiency

UNKNOWN PHASE4

Management of Adrenal Emergency in Germany

NCT03426332

Adrenal Insufficiency

COMPLETED

The Evaluation and Management of Patients With Acute ChesT Pain in China

NCT02536677

Acute Chest Pain Acute Coronary Syndrome

COMPLETED

Renal Sympathetic Denervation for Patients With Chronic Heart Failure

NCT01790906

Chronic Heart Failure

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adrenal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adrenal cohort

Aged between 18 and 75 years; diagnosed with adrenal diseases, including primary aldosteronism, pheochromocytoma, Cushing's syndrome, congenital adrenal hyperplasia, adrenocortical carcinoma, etc.; in stable condition, capable of tolerating all examinations and follow-ups required by the study.

Receive adrenal surgery, radiotherapy, and/or medication therapy based on diagnosis and subtype classification.

Intervention Type OTHER

Receive adrenal surgery, radiotherapy, and/or medication therapy based on diagnosis and subtype classification.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Receive adrenal surgery, radiotherapy, and/or medication therapy based on diagnosis and subtype classification.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A signed and dated informed consent form
* Commitment to abide by the study procedures and cooperate with the implementation of the entire study process
* Patients diagnosed with adrenal diseases, including aldosteronism, Cushing's syndrome, pheochromocytoma, adrenocortical carcinoma, and congenital adrenal hyperplasia; regardless of whether they have received adrenal surgery, radiotherapy, and/or medication therapy
* Aged between 18 and 75 years

Exclusion Criteria

* Subjects meeting any of the following criteria will be excluded from this study:
* Refuse to sign the informed consent form
* Patients without adrenal diseases
* Have specified diseases or conditions (physical or psychological, identified through physical examination) that warrant exclusion from the study

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No